New Key Statistics Module, Z-Score and F-Score
TSX:MDP Key Ratios
Market Cap C$ M | 38.89 |
Enterprise Value C$ M | 99.18 |
P/E(ttm) | 3.88 |
PE Ratio without NRI | 4.33 |
Forward PE Ratio | 6.45 |
Price/Book | 0.98 |
Price/Sales | 0.22 |
Price/Free Cash Flow | 1.23 |
Price/Owner Earnings | 5.23 |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 155.00 |
EPS (TTM) C$ | 0.41 |
Beneish M-Score | -2.82 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 78.50 |
EV-to-EBIT | 5.31 |
EV-to-EBITDA | 3.73 |
PEG | -- |
Shares Outstanding M | 24.46 |
Net Margin (%) | 5.16 |
Operating Margin % | 11.04 |
Pre-tax Margin (%) | -0.77 |
Quick Ratio | 0.70 |
Current Ratio | 1.11 |
ROA % (ttm) | 3.72 |
ROE % (ttm) | 26.67 |
ROIC % (ttm) | -64.28 |
Dividend Yield % | -- |
Altman Z-Score | 0.63 |
TSX:MDP Number of Guru Trades
TSX:MDP Volume of Guru Trades
Gurus Latest Trades with TSX:MDP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:MDP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Medexus Pharmaceuticals Inc Insider Transactions
No Available Data